Page 25 - Process Development News Today

RTW Leads $106 Million Financing Round in Tenaya Therapeutics RTW Venture Fund Limited (the "Company"), the London Stock Exchange-listed investment company focused on identifying transformative assets with high growth potential across the life sciences sector, is pleased to note the announcement by Tenaya Therapeutics, Inc. ("Tenaya") on 01 March 2021 of its completion of a $106 million Series C financing round led by RTW Investments, LP (the "Investment Manager"). The Company, alongside other...

Share New Delhi: The Department of Biotechnology (DBT) today celebrated its 35th Foundation Day. “The Department’s role in the fight against COVID-19 pandemic is commendable. A special grant of Rs. 900 crore under Atmanirbhar Bharat 3.0 has been allocated to the Department for the COVID-SURAKSHA towards development of vaccines against COVID-19”, speaker at the function pointed out. The function to celebrate the 35th Foundation Day of DBT was held through video-conferencing.Speakers highli...

Opportunities for food technology providers in cultivated food industry Pallevi Srivastva, Ph.D., Lead Scientist, Head of Cell Culture Media & Process Development, Wild Type, Inc. Pallevi Srivastva, Ph.D., Lead Scientist, Head of Cell Culture Media & Process Development, Wild Type, Inc. The annual global demand for seafood per capita has more than doubled over the last 50 years, from 10 kilograms in 1960 to 20 kilograms in 2014 (FAO). Commensurate increases in supply have come pr...

February 4, 2021 Registration is now open for the first three noncredit certificate courses for Washington State University Vancouver’s new Professional and Corporate Education (PACE) program. The courses will be offered online in the evenings via Zoom videoconference beginning in March. The goal of PACE is “to serve the lifelong learning and career development needs of individuals, organizations and the community,” said Hakan Gurocak, director of the PACE program and a professor of mecha...

Share this article Share this article SAN JUAN, Puerto Rico, Feb. 3, 2021 /PRNewswire/ -- In line with its mission of promoting investment and economic development in the Island, economic development organization Invest Puerto Rico ("InvestPR"), revealed two major successes for its bioscience sector. CytoImmune Therapeutics, Inc. and Biosimilar Solutions, LLC, each committed to establishing operations on the Island to develop their biotechnology products.   Invest Puerto Rico elevates the I...

Geltor Adds Ingredient Science Industry Veterans to Leadership Team News provided by Share this article SAN LEANDRO, Calif., Feb. 2, 2021 /PRNewswire/ -- Biodesign company  Geltor, Inc. today announced the addition of three new senior executives to its leadership team to drive product innovation, operational excellence, and commercial growth for its specialty proteins. Joining the company are Scott Fabro as Vice President of Business Development, Alex Patist as Vice President of Operations, an...

Joint Team from MIT and Synlogic Named a Biotechnology Grand Challenge Winner by Air Force Research Laboratory - Synlogic to provide bioprocess and manufacturing in joint effort to engineer novel investigational medicines to address battle fatigue - News provided by Share this article Share this article CAMBRIDGE, Mass., Feb. 2, 2021 /PRNewswire/ -- A collaboration between MIT Voigt Lab and Synlogic, Inc. (Nasdaq: SYBX), a clinical stage company bringing the transformative potential of syntheti...

DiNAQOR Establishes New GMP Manufacturing Facility in Zurich News provided by Share this article Share this article PFÄFFIKON, Switzerland, Jan. 11, 2021 /PRNewswire/ -- DiNAQOR, a gene therapy platform company, today announced that it will establish its own GMP manufacturing capabilities with a new facility in the Bio-Technopark Schlieren-Zürich. This state-of-the-art 1200 sqm (13,000 sq. ft) GMP facility will produce adeno-associated virus (AAV)-based gene therapies and is co-located w...

Introduction To ASTM E3263-20: By Andrew Walsh, Ralph Basile, Ovais Mohammad, Stéphane Cousin, Mariann Neverovitch, and Osamu Shirokizawa Part of the series Visual inspection has been widely used for many years by the pharmaceutical, biologics, and medical device industries after cleaning to release manufacturing equipment and devices. However, visual inspection has never been demonstrated to be an effective, reliable, or safe method to use for these inspections. Recently, the European Medic...

Fujifilm Diosynth Biotechnologies will establish a new process development and manufacturing facility for viral vectors and advanced therapies.